SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
109,333
109,333
128,367
146,444
Cost of Revenue
-
26,756
47,218
35,843
Gross Profit
-
82,577
81,149
110,601
Operating Expenses
Research Development
105,717
94,956
65,895
58,936
Selling General and Administrative
90,893
90,700
84,267
87,347
Total Operating Expenses
224,708
213,754
177,809
172,229
Operating Income or Loss
-142,131
-131,177
-96,660
-61,628
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-11,623
11,507
-4,568
238
Income Before Tax
-149,534
-120,010
-108,026
-70,825
Income Tax Expense
-7,814
1
-16,778
-2,313
Income from Continuing Operations
-141,720
-120,011
-91,248
-68,512
Net Income
-122,754
-120,011
-91,248
-68,512
Net Income available to common shareholders
-122,754
-120,011
-91,248
-68,512
Reported EPS
Basic
-
-1.16
-1.07
-0.94
Diluted
-
-1.16
-1.07
-0.94
Weighted average shares outstanding
Basic
-
103,306
85,116
72,824
Diluted
-
103,306
85,116
72,824
EBITDA
-
-103,079
-69,013
-35,682